Zhai, Z., Vaddi, P. K., Samson, J. M., Takegami, T., & Fujita, M. (2020). NLRP1 Functions Downstream of the MAPK/ERK Signaling via ATF4 and Contributes to Acquired Targeted Therapy Resistance in Human Metastatic Melanoma. Pharmaceuticals (Basel).
Style de citation ChicagoZhai, Zili, Prasanna K. Vaddi, Jenny Mae Samson, Tomoya Takegami, et Mayumi Fujita. "NLRP1 Functions Downstream of the MAPK/ERK Signaling Via ATF4 and Contributes to Acquired Targeted Therapy Resistance in Human Metastatic Melanoma." Pharmaceuticals (Basel) 2020.
Style de citation MLAZhai, Zili, et al. "NLRP1 Functions Downstream of the MAPK/ERK Signaling Via ATF4 and Contributes to Acquired Targeted Therapy Resistance in Human Metastatic Melanoma." Pharmaceuticals (Basel) 2020.
Attention : ces citations peuvent ne pas être correctes à 100%.